Bronchodilators: New developments

Autor:	Tattersfield Ae
Rok vydání:	1992
Předmět:	Allergy medicine.medical_specialty business.industry medicine.drug_class General Medicine medicine.disease respiratory tract diseases Clinical Practice Immunopathology Bronchodilator Immunology medicine Theophylline business Intensive care medicine Fenoterol medicine.drug Asthma
Zdroj:	British Medical Bulletin. 48:190-204
ISSN:	1471-8391 0007-1420
DOI:	10.1093/oxfordjournals.bmb.a072534
Popis:	This chapter is concerned with recent controversies and new developments in the area of established bronchodilators, namely beta-agonists, antimuscarinic drugs and methylxanthines. It focuses on the studies concerned with fenoterol and its possible role in asthma deaths in New Zealand, the new long-acting beta-agonists and the place of beta-agonists in the treatment of asthma. The possible reasons for the fact that antimuscarinic drugs have been less effective in general than beta-agonists in asthma are explored and the difficulties of using theophylline in clinical practice and its role in the treatment of asthma are discussed.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e939ed99e61596d9e6381f18a0c85c14 https://doi.org/10.1093/oxfordjournals.bmb.a072534 Zobrazit plný text záznamu